Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Polyrizon Ltd. ( (PLRZ) ) has issued an update.
On August 14, 2025, Polyrizon Ltd. announced it has regained compliance with Nasdaq listing requirements. The company received confirmation from the Nasdaq Hearings Panel that it met the minimum bid price requirement and satisfied all conditions outlined in a previous decision. This allows Polyrizon to continue trading on the Nasdaq Capital Market under the ticker symbol ‘PLRZ’, which is a significant step for maintaining its market presence and investor confidence.
More about Polyrizon Ltd.
Polyrizon Ltd. is a biotechnology company that specializes in developing innovative medical device hydrogels delivered as nasal sprays. These products form a thin hydrogel-based shield in the nasal cavity to protect against viruses and allergens. The company is further developing its Capture and Contain (C&C) hydrogel technology for enhanced bioadhesion and prolonged retention, as well as exploring the nasal delivery of active pharmaceutical ingredients through its Trap and Target (T&T) technology.
Average Trading Volume: 8,795,589
Technical Sentiment Signal: Strong Sell
Current Market Cap: $5.94M
For an in-depth examination of PLRZ stock, go to TipRanks’ Overview page.